Rapidly progressive rhino-orbito-cerebral mucormycosis in a patient with type 2 diabetes: A case report.

about

Rapidly progressive rhino-orbito-cerebral mucormycosis in a patient with type 2 diabetes: A case report.

Item

http://www.wikidata.org/entity/Q40234553

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rapidly progressive rhino-orbi ...... ype 2 diabetes: A case report.

@en

type

Item

label

Rapidly progressive rhino-orbi ...... ype 2 diabetes: A case report.

@en

prefLabel

Rapidly progressive rhino-orbi ...... ype 2 diabetes: A case report.

@en

P1476

Rapidly progressive rhino-orbi ...... ype 2 diabetes: A case report.

@en

P2093

Hong Zhou

http://www.w3.org/2001/XMLSchema#string

Mian Wang

http://www.w3.org/2001/XMLSchema#string

Sheng-Ou Su

http://www.w3.org/2001/XMLSchema#string

Yan-Xia Chen

http://www.w3.org/2001/XMLSchema#string

Yin-Xi He

http://www.w3.org/2001/XMLSchema#string

P2860

Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report

Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole.

Host cell invasion in mucormycosis: role of iron

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.

Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.

Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

P304

1054-1056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4074

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28450941

http://www.w3.org/2001/XMLSchema#string

P932

5403418

http://www.w3.org/2001/XMLSchema#string